Abbott Laboratories Statement of Changes in Director/PDMR Shareholding (1451L)
29 Setembro 2016 - 3:00AM
UK Regulatory
TIDMABT
RNS Number : 1451L
Abbott Laboratories
28 September 2016
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS
BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
AND PERSONS CLOSELY ASSOCIATED WITH THEM
------------------------------------------------------------------
Details of the person discharging managerial
1. responsibilities/person closely associated
---- ------------------------------------------------------------
a) Name Michael J. Warmuth
---- ------------------------ ----------------------------------
2. Reason for the notification
---- ------------------------------------------------------------
Executive Vice President,
a) Position / status Established Pharmaceuticals
---- ------------------------ ----------------------------------
Initial notification
b) / amendment Initial Notification
---- ------------------------ ----------------------------------
Details of the issuer, emission allowance
market participant, auction platform, auctioneer
3. or auction monitor
---- ------------------------------------------------------------
a) Name Abbott Laboratories
---- ------------------------ ---------------------- ----------
b) LEI HQD377W2YR662HK5JX27
---- ------------------------ ---------------------- ----------
Details of the transaction(s)
Section to be repeated for (i) each type
of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where
4. transactions have been conducted
---- ------------------------------------------------------------
Description
of the financial
instrument, Common Shares without par
a) type of instrument value
------------------------ ----------------------------------
Identification
code US0028241000
---- ------------------------ ----------------------------------
Nature of the
b) transaction Gifts of ABT stock
---- ------------------------ ----------------------------------
Price(s) Volume(s)
---- ------------------------ ---------------------- ----------
c) USD 0 12,152
------------------------------ --------------------- ----------
Aggregated information
---------------
- Aggregated
volume
---------------
d) - Price
---- ------------------------------------------------ ----------
Date of the
e) transaction 2016-08-31
---- ------------------------ ----------------------------------
Place of the
f) transaction New York Stock Exchange (XNYS)
---- ------------------------ ----------------------------------
Details of the transaction(s)
Section to be repeated for (i) each type
of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where
5 transactions have been conducted
---- ------------------------------------------------------------
Description
of the financial
instrument,
a) type of instrument
------------------------------------------------ ----------
Identification
code
------------------------------------------------ ---------------
Nature of the
b) transaction
---- ------------------------------------------------ ----------
Price(s) Volume(s)
---------------------------------------------------- ----------
c)
------------------------------------------------------ ----------
Aggregated information
---------------
- Aggregated
volume
---------------
d) - Price
---- ------------------------------------------------ ----------
Date of the
e) transaction
---- ------------------------------------------------ ----------
Place of the
f) transaction
---- ------------------------------------------------ ----------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAFNPAFXKEAF
(END) Dow Jones Newswires
September 29, 2016 02:00 ET (06:00 GMT)
Abbott Labs (LSE:ABT)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Abbott Labs (LSE:ABT)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
Notícias em tempo-real sobre Abbott Labs da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Abbott Labs